LINE-1 and Alu methylation signatures in autism spectrum disorder and their associations with the expression of autism-related genes
Long interspersed nucleotide element-1 (LINE-1) and Alu elements are retrotransposons whose abilities cause abnormal gene expression and genomic instability. Several studies have focused on DNA methylation profiling of gene regions, but the locus-specific methylation of LINE-1 and Alu elements has n...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2022-08, Vol.12 (1), p.13970-13970, Article 13970 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Long interspersed nucleotide element-1 (LINE-1) and
Alu
elements are retrotransposons whose abilities cause abnormal gene expression and genomic instability. Several studies have focused on DNA methylation profiling of gene regions, but the locus-specific methylation of LINE-1 and
Alu
elements has not been identified in autism spectrum disorder (ASD). Here we interrogated locus- and family-specific methylation profiles of LINE-1 and
Alu
elements in ASD whole blood using publicly-available Illumina Infinium 450 K methylation datasets from heterogeneous ASD and ASD variants (
Chromodomain Helicase DNA-binding 8
(
CHD8
) and 16p11.2del). Total DNA methylation of repetitive elements were notably hypomethylated exclusively in ASD with
CHD8
variants. Methylation alteration in a family-specific manner including L1P, L1H, HAL,
AluJ
, and
AluS
families were observed in the heterogeneous ASD and ASD with
CHD8
variants. Moreover, LINE-1 and
Alu
methylation within target genes is inversely related to the expression level in each ASD variant. The DNA methylation signatures of the LINE-1 and
Alu
elements in ASD whole blood, as well as their associations with the expression of ASD-related genes, have been identified. If confirmed in future larger studies, these findings may contribute to the identification of epigenomic biomarkers of ASD. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-022-18232-6 |